{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:21:08Z","timestamp":1791890468525,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00417-018-4163-x","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T06:28:29Z","timestamp":1540016909000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Saffron therapy for the treatment of mild\/moderate age-related macular degeneration: a randomised clinical trial"],"prefix":"10.1007","volume":"257","author":[{"given":"Geoffrey K.","family":"Broadhead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Schlub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"key":"4163_CR1","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.ophtha.2012.11.041","volume":"120","author":"R Klein","year":"2013","unstructured":"Klein R, Lee KE, Gangnon RE, Klein BE (2013) Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study. Ophthalmology 120:1210\u20131219","journal-title":"Ophthalmology"},{"key":"4163_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419\u20131431","journal-title":"N Engl J Med"},{"key":"4163_CR3","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432\u20131444","journal-title":"N Engl J Med"},{"key":"4163_CR4","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.ophtha.2013.01.021","volume":"120","author":"EY Chew","year":"2013","unstructured":"Chew EY, Clemons TE, Agron E et al (2013) Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology 120:1604\u20131611","journal-title":"Ophthalmology"},{"key":"4163_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","unstructured":"Age-Related Eye Disease Study Research Group (2001) A randomized placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417\u20131436","journal-title":"Arch Ophthalmol"},{"key":"4163_CR6","first-page":"2005","volume":"2309","author":"Age-Related Eye Disease Study 2 Research Group","year":"2013","unstructured":"Age-Related Eye Disease Study 2 Research Group (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the age-related eye disease study 2 (AREDS2) randomized clinical trial. JAMA 2309:2005\u20132015","journal-title":"JAMA"},{"key":"4163_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JPD-130173","volume":"3","author":"S Purushothuman","year":"2013","unstructured":"Purushothuman S et al (2013) Saffron pre-treatment offers neuroprotection to nigral and retinal dopaminergic cells of MPTP-treated mice. J Parkinsons Dis 3:77\u201383","journal-title":"J Parkinsons Dis"},{"key":"4163_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00213-009-1706-1","volume":"207","author":"S Akhondzadeh","year":"2010","unstructured":"Akhondzadeh S, Shafiee Sabet M, Harirchian MH et al (2010) A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacology 207:637\u2013643","journal-title":"Psychopharmacology"},{"key":"4163_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/10408390902773003","volume":"50","author":"SZ Bathaie","year":"2010","unstructured":"Bathaie SZ, Mousavi SZ (2010) New applications and mechanisms of action of saffron and its important ingredients. Crit Rev Food Sci Nutr 50:761\u2013786","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4163_CR10","first-page":"39","volume":"16","author":"AH Mohamadpour","year":"2013","unstructured":"Mohamadpour AH et al (2013) Safety evaluation of Crocin (a constituent of saffron) tablets in healthy volunteers. Iran J Basic Med Sci 16:39\u201346","journal-title":"Iran J Basic Med Sci"},{"key":"4163_CR11","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1167\/iovs.09-4995","volume":"51","author":"B Falsini","year":"2010","unstructured":"Falsini B et al (2010) Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci 51:6118\u20136124","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4163_CR12","doi-asserted-by":"publisher","first-page":"429124","DOI":"10.1155\/2012\/429124","volume":"2012","author":"M Piccardi","year":"2012","unstructured":"Piccardi M et al (2012) A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration: sustained benefits to central retinal function. Evid Based Complement Alternat Med 2012:429124","journal-title":"Evid Based Complement Alternat Med"},{"issue":"5","key":"4163_CR13","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0002-9394(01)01218-1","volume":"132","author":"Age-Related Eye Disease Study Research Group","year":"2001","unstructured":"Age-Related Eye Disease Study Research Group (2001) The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6. Am J Ophthalmol 132(5):668\u2013681","journal-title":"Am J Ophthalmol"},{"key":"4163_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0002-9394(00)00732-7","volume":"131","author":"Age-Related Eye Disease Study Research Group","year":"2001","unstructured":"Age-Related Eye Disease Study Research Group (2001) The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. Am J Ophthalmol 131:167\u2013175","journal-title":"Am J Ophthalmol"},{"key":"4163_CR15","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1167\/iovs.04-0253","volume":"45","author":"JA Phipps","year":"2004","unstructured":"Phipps JA, Dang TM, Vingrys AJ, Guymer RH (2004) Flicker perimetry losses in age-related macular degeneration. Invest Ophthalmol Vis Sci 45:3355\u20133360","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4163_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-011-9296-8","volume":"124","author":"DC Hood","year":"2012","unstructured":"Hood DC, Bach M, Brigell M et al (2012) ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol 124:1\u201313","journal-title":"Doc Ophthalmol"},{"key":"4163_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL et al (2015) ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130:1\u201312","journal-title":"Doc Ophthalmol"},{"key":"4163_CR18","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1167\/iovs.12-10715","volume":"54","author":"IJ Murray","year":"2013","unstructured":"Murray IJ et al (2013) Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study. Invest Ophthalmol Vis Sci 54:1781\u20131788","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4163_CR19","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.ophtha.2013.01.005","volume":"120","author":"EH Souied","year":"2013","unstructured":"Souied EH, Delcourt C, Querques G et al (2013) Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the nutritional AMD treatment 2 study. Ophthalmology 120:1619\u20131631","journal-title":"Ophthalmology"},{"key":"4163_CR20","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.3390\/nu5072405","volume":"5","author":"M Schleicher","year":"2013","unstructured":"Schleicher M, Weikel K, Garber C, Taylor A (2013) Diminishing risk for age-related macular degeneration with nutrition: a current view. Nutrients 5:2405\u20132456","journal-title":"Nutrients"},{"key":"4163_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1017\/S0952523814000108","volume":"31","author":"S Bisti","year":"2014","unstructured":"Bisti S, Maccarone R, Falsini B (2014) Saffron and retina: neuroprotection and pharmacokinetics. Vis Neurosci 31:355\u2013361","journal-title":"Vis Neurosci"},{"key":"4163_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000439026","volume":"54","author":"L Chen","year":"2015","unstructured":"Chen L, Qi Y, Yang X (2015) Neuroprotective effects of crocin against oxidative stress induced by ischemia\/reperfusion injury in rat retina. Ophthalmic Res 54:157\u2013168","journal-title":"Ophthalmic Res"},{"key":"4163_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2013.02.007","volume":"703","author":"F Ishizuka","year":"2013","unstructured":"Ishizuka F et al (2013) Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice. Eur J Pharmacol 703:1\u201310","journal-title":"Eur J Pharmacol"},{"key":"4163_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ajo.2012.04.014","volume":"154","author":"L Ma","year":"2012","unstructured":"Ma L, Dou HL, Huang YM et al (2012) Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial. Am J Ophthalmol 154:625\u2013634","journal-title":"Am J Ophthalmol"},{"key":"4163_CR25","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1017\/S0007114512004187","volume":"109","author":"EJ Berrow","year":"2013","unstructured":"Berrow EJ, Bartlett HE, Eperjesi F, Gibson JM (2013) The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy -- a randomised controlled trial. Br J Nutr 109:2008\u20132014","journal-title":"Br J Nutr"},{"key":"4163_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10633-015-9507-9","volume":"131","author":"L Ambrosio","year":"2015","unstructured":"Ambrosio L et al (2015) The value of multifocal electroretinography to predict progressive visual acuity loss in early AMD. Doc Ophthalmol 131:125\u2013135","journal-title":"Doc Ophthalmol"},{"key":"4163_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10633-014-9460-z","volume":"129","author":"GF Yavas","year":"2014","unstructured":"Yavas GF, Kusbeci T, Inan UU (2014) Multifocal electroretinography in subjects with age-related macular degeneration. Doc Ophthalmol 129:167\u2013175","journal-title":"Doc Ophthalmol"},{"key":"4163_CR28","first-page":"1673","volume":"43","author":"DC Hood","year":"2002","unstructured":"Hood DC, Frishman LJ, Saszik S, Viswanathan S (2002) Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci 43:1673\u20131685","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4163_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10633-016-9523-4","volume":"132","author":"S Yang","year":"2016","unstructured":"Yang S et al (2016) Photoreceptor dysfunction in early and intermediate age-related macular degeneration assessed with mfERG and spectral domain OCT. Doc Ophthalmol 132:17\u201326","journal-title":"Doc Ophthalmol"},{"key":"4163_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/bjo.85.3.287","volume":"85","author":"J Li","year":"2001","unstructured":"Li J, Tso MO, Lam TT (2001) Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration. Br J Ophthalmol 85:287\u2013290","journal-title":"Br J Ophthalmol"},{"key":"4163_CR31","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1001\/archopht.121.10.1404","volume":"121","author":"C Gerth","year":"2003","unstructured":"Gerth C et al (2003) Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen. Arch Ophthalmol 121:1404\u20131414","journal-title":"Arch Ophthalmol"},{"key":"4163_CR32","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.1167\/iovs.14-14407","volume":"55","author":"Z Wu","year":"2014","unstructured":"Wu Z, Ayton LN, Guymer RH, Luu CD (2014) Comparison between multifocal electroretinography and microperimetry in age-related macular degeneration. Invest Ophthalmol Vis Sci 55:6431\u20136439","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4163_CR33","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/archopht.119.10.1439","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","unstructured":"Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no 9. Arch Ophthalmol 119:1439\u20131452","journal-title":"Arch Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-018-4163-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4163-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4163-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T16:45:50Z","timestamp":1605285950000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-018-4163-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4163"],"URL":"https:\/\/doi.org\/10.1007\/s00417-018-4163-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,20]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licencing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}